Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration
Against the backdrop of mass parenteral immunization by present pertussis vaccines the incidence rate of pertussis is recorded in many countries, as well as among adolescents and adults, according to the World Health Organisation data. The number of cases of pertussis complicated to detect is increa...
Main Authors: | L. N. Sinyashina, E. G. Semin, A. Yu. Medkova, R. A. Siundiukova, G. I. Karataev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2019-01-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/625 |
Similar Items
-
Pre-clinical study of protective potency of candidate recombinant live pertussis vaccine for intranasal administration
by: L. N. Sinyashina, et al.
Published: (2019-08-01) -
Preclinical studies of safety, immunogenicity and protective activity of attenuated Bordetella pertussis bacteria on the Macaca mulatta model
by: Alisa Yu. Medkova, et al.
Published: (2020-09-01) -
A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
by: A. Yu. Medkova, et al.
Published: (2021-02-01) -
CONSTRUCTION OF RECOMBINANT ATTENUATED BORDETELLA PERTUSSIS BACTERIA OF PTXP3 GENOTYPE
by: E. G. Semin, et al.
Published: (2018-08-01) -
Epizootic pertussis focus of hamadryad baboons
by: A. Yu. Medkova, et al.
Published: (2015-11-01)